Investor Presentation
GVB: A TRANSFORMATIONAL
ACQUISITION
The acquisition of GVB allows 22nd Century to leverage its expertise in receptor and plant science to
develop its hemp/cannabis franchise and add significant scale in the immediate-term
Market Leadership
in Hemp-Derived Products
Compelling Financial Impact
Key Strategic Benefits
and Synergies
▪ GVB is wi regarded as a best-in-class operator with an estimated 15% share
of the hemp-derived active ingredients market
■ Control from biomass to ingredients to finished goods ensuring attractive prices,
quality, purity (99%+ isolates) and traceability
■ CGMP and NSF-audited facility
22ND CENTURY GROUP
Significantly increases 22nd Century's revenue and accelerates the path to profitability
■ Immediately accretive to top and bottom line
▪ Manageable working capital investments and limited capital expenditure requirements
to drive significant growth
▪ GVB's production and formulation capabilities are uniquely suited to leverage and monetize
22nd Century's IP portfolio and research capabilities
▪ Crop developments by 22nd Century will lead to dramatic margin expansion for GVB sales
▪ Manufacturing capabilities for various form factors represent an under-penetrated growth
opportunity that 22nd Century leadership is well-qualified to capitalize on
▪ Deepens global footprint in geographic markets targeted for growth
15View entire presentation